2018 Cholangiocarcinoma Annual Conference

2018 Cholangiocarcinoma Annual Conference

Programme du congrès

Lieu : Utah

Pays : Etats-Unis

Langue : ENG

Date de début :

Date de fin :

Spécialités : Oncologie

The Cholangiocarcinoma Foundation's Annual Conference seeks to develop sustainable participation of the medical and research communities in the field of cholangiocarcinoma

Toutes les vidéos du congrès ( 50 vidéos )

Suggérer une vidéo

Day 2 - Mitochondrial Dysfunction

Day 2 - Mitochondrial Dysfunction
  • Date : 02/02/2021
  • 1    
    0

Day 1 - Social Media

Day 1 - Social Media
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Molecular Pathology

Day 2 - Molecular Pathology
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Genomics of CCA

Day 2 - Genomics of CCA
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Patient Perspective

Day 2 - Patient Perspective
  • Date : 02/02/2021
  • 0    
    0

Day 2 - ICRN Update

Day 2 - ICRN Update
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Panel Discussion

Day 2 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Global Risk Factors

Day 2 - Global Risk Factors
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Patterns/Outcomes from CCA DB

Day 2 - Patterns/Outcomes from CCA DB
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Incidence of Cholangiocarcinoma

Day 2 - Incidence of Cholangiocarcinoma
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Welcome

Day 2 - Welcome
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Caregiver Perspective

Day 1 - Caregiver Perspective
  • Date : 02/02/2021
  • 0    
    0

Day 1 - CholangioConnect

Day 1 - CholangioConnect
  • Date : 02/02/2021
  • 0    
    0

Day 2 - FGFR Signaling

Day 2 - FGFR Signaling
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Advocacy Update

Day 1 - Advocacy Update
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Nurturing Hope

Day 1 - Nurturing Hope
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Complimentary Medicine

Day 1 - Complimentary Medicine
  • Date : 02/02/2021
  • 0    
    0

Day 1 - PCORI

Day 1 - PCORI
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Cancer & Nutrition

Day 1 - Cancer & Nutrition
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Management of Biliary Obstruction

Day 1 - Management of Biliary Obstruction
  • Date : 02/02/2021
  • 0    
    0

Day 1 - FDA Drug Approval Process

Day 1 - FDA Drug Approval Process
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Immunotherapies

Day 1 - Immunotherapies
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Epidemiology of Cholangiocarcinoma

Day 1 - Epidemiology of Cholangiocarcinoma
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Patient Perspective

Day 1 - Patient Perspective
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Welcome/CCF Update

Day 1 - Welcome/CCF Update
  • Date : 02/02/2021
  • 0    
    0

Day 1 - Basic Research Update

Day 1 - Basic Research Update
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Hippo Signaling Pathways

Day 2 - Hippo Signaling Pathways
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Panel Discussion

Day 3 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 3 - FDA Expedited Programs

Day 3 - FDA Expedited Programs
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Biomarker Data from ABC-06

Day 3 - Biomarker Data from ABC-06
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Clinical Trial Design

Day 3 - Clinical Trial Design
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Systemic Therapy for CCA

Day 3 - Systemic Therapy for CCA
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Nursing Advisory Board

Day 3 - Nursing Advisory Board
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Panel Discussion

Day 3 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Adjuvant Therapy

Day 3 - Adjuvant Therapy
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Novel Approaches to Radiotherapy

Day 3 - Novel Approaches to Radiotherapy
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Intrahepatic CCA

Day 3 - Intrahepatic CCA
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Patient Perspective

Day 3 - Patient Perspective
  • Date : 02/02/2021
  • 0    
    0

Day 3 - Closing Remarks

Day 3 - Closing Remarks
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Immunotherapy

Day 2 - Immunotherapy
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Next Generation Mouse Model

Day 2 - Next Generation Mouse Model
  • Date : 02/02/2021
  • 0    
    0

Day 2 - A Distributed Hepaocyte

Day 2 - A Distributed Hepaocyte
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Panel Discussion

Day 2 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 2 - IDH Mutations

Day 2 - IDH Mutations
  • Date : 02/02/2021
  • 0    
    0

Day 2 - IDH Inhibitor Trials

Day 2 - IDH Inhibitor Trials
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Liabilities of IDH Mutant Cells

Day 2 - Liabilities of IDH Mutant Cells
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Volunteer Meeting

Day 2 - Volunteer Meeting
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Panel Discussion

Day 2 - Panel Discussion
  • Date : 02/02/2021
  • 0    
    0

Day 2 - FGFR Inhibition

Day 2 - FGFR Inhibition
  • Date : 02/02/2021
  • 0    
    0

Day 2 - Targeting The Hippo Pathway

Day 2 - Targeting The Hippo Pathway
  • Date : 02/02/2021
  • 0    
    0

Sélection de congrès

Congrès ESMO 2026

Congrès ESMO 2026
  • Date : 23/10/2026
  • 20242    
    0

11th International Congress on Cancer Science and Radiology 2026

11th International Congress on Cancer Science and Radiology 2026
  • Date : 22/07/2026
  • 871    
    0

12ᵉ Congrès Mondial sur la Recherche et la Thérapie du Cancer

12ᵉ Congrès Mondial sur la Recherche et la Thérapie du Cancer
  • Date : 29/06/2026
  • 4082    
    0

Congrès de l’ESTRO 2026

Congrès de l’ESTRO 2026
  • Date : 15/05/2026
  • 6405    
    0

Le 12e Congrès mondial sur les controverses dans le myélome multiple (COMy)

Le 12e Congrès mondial sur les controverses dans le myélome multiple (COMy)
  • Date : 14/05/2026
  • 1352    
    0